LEADER 02104nam  2200361   450 
001 9910598004603321
005 20230220084845.0
035   $a(CKB)4920000000094979
035   $a(NjHacI)994920000000094979
035   $a(EXLCZ)994920000000094979
100   $a20230220d2018      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAptamers /$fJulian Tanner, Andrew Brian Kinghorn, Yee-Wai Cheung, editors
210  1$aBasel :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2018.
215   $a1 online resource (298 pages)
311   $a3-03897-059-X 
330   $aAptamers are in vitro selected oligonucleotides capable of specific, high-affinity binding to a wide variety of target molecules. These features enable their application in diagnostics, therapeutics, targeted delivery, fluorescence imaging, and biosensing. Aptamers are isolated via the systematic evolution of ligands by exponential enrichment (SELEX), an iterative cycle of selection and amplification steps that enriches a randomly synthesised oligonucleotide library to a pool of specific, high-affinity aptamers. Since the inception of aptamers in 1990, the methods by which aptamers are selected have been improved, yielding a robust system capable of producing aptamers rapidly and at low cost. Recently, there has been an explosion in the field of aptamers including innovations in enhanced selection strategies, bioinformatics approaches, riboswitches, unnatural base pairs, nucleic acid nanostructures, and DNAzymes. This book combines excellent reviews with primary research articles to provide multidisciplinary perspectives on the frontiers of aptamer science in 2018.
606   $aMolecular biology
615  0$aMolecular biology.
676   $a572.8
702   $aTanner$b Julian
702   $aKinghorn$b Andrew Brian
702   $aCheung$b Yee-Wai
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910598004603321
996   $aAptamers$91965981
997   $aUNINA